| [1] |
Kahn SR, Galanaud JP, Vedantham S, et al. Guidance for the prevention and treatment of the post-thrombotic syndrome[J]. J Thromb Thrombolysis, 2016, 41(1): 144-153.
|
| [2] |
Rabinovich A, Kahn SR. The postthrombotic syndrome: current evidence and future challenges[J]. J Thromb Haemost, 2017, 15(2): 230-241.
|
| [3] |
Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): 737-801.
|
| [4] |
Kahn SR, Comerota AJ, Cushman M, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association[J]. Circulation, 2014, 130(18): 1636-1661.
|
| [5] |
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: chest guideline and expert panel report[J]. Chest, 2016, 149(2): 315-352.
|
| [6] |
Tan M, Mos IC, Klok FA, et al. Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review[J]. Br J Haematol, 2011, 153(2): 168-178.
|
| [7] |
Vedantham S. Knowns and unknowns in managing postthrombotic syndrome[J]. Semin Intervent Radiol, 2017, 34(1): 68-72.
|
| [8] |
Farrell JJ, Sutter C, Tavri S, et al. Incidence and interventions for post-thrombotic syndrome[J]. Cardiovasc Diagn Ther, 2016, 6(6): 623-631.
|
| [9] |
Bharath V, Kahn SR, Lazo-Langner A, et al. Genetic polymorphisms of vein wall remodeling in chronic venous disease: an arrativeand systematic review[J]. Blood, 2014, 124(8): 1242-1250.
|
| [10] |
Ginsberg JS, Hirsh J, Julian J, et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study[J]. Arch Intern Med, 2001, 161: 2105-2109.
|
| [11] |
Rabinovich A, Kahn SR. How to predict and diagnose postthrombotic syndrome[J]. Pol Arch Med Wewn, 2014, 124(7-8): 410-416.
|
| [12] |
Milan M, Sarolo L, Callegari E, et al. High rate of inter-observer agreement between professional-rated scores of the Villalta scalefor the assessment of the post-thrombotic syndrome[J]. Thromb Res, 2016, 144: 182-183.
|
| [13] |
Jayaraj A, Meissner MH. A comparison of Villalta-Prandoni scale and venous clinical severity score in the assessment of post thrombotic syndrome[J]. Ann Vasc Surg, 2014, 28(2): 313-317.
|
| [14] |
Blomgren L, Engström J, Rosfors SA, et al. comparison of magnetic resonance venography findings and venous occlusion plethysmography variables in postthrombotic syndrome[J]. Vascular, 2017, 25(4): 406-411.
|
| [15] |
Liu D, Peterson E, Dooner J, et al. Diagnosis and managementof iliofemoral deep vein thrombosis: clinical practice guideline[J]. CMAJ, 2015, 187(17): 1288-1296.
|
| [16] |
Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2): 278-325.
|
| [17] |
Kearon C, Akl EA, Comerota AJ, et al. Antithrombotictherapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2): 419-494.
|
| [18] |
Hull RD, Townshend G. Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: an update of the evidence[J]. Thromb Haemost, 2013, 110(1): 14-22.
|
| [19] |
Carman TL. Prevention of the post-thrombotic syndrome[J]. Curr Treat Options Cardiovasc Med, 2016, 18(8): 51.
|
| [20] |
Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: ACCP evidence-based clinical practice guidelines (8th edition)[J]. Chest, 2008, 133(6): 454-545.
|
| [21] |
Berntsen CF, Kristiansen A, Akl EA, et al. Compression stockings for preventing the postthrombotic syndrome in patients with deepvein thrombosis[J]. Am J Med, 2016, 129(4): 447.
|
| [22] |
Diehm N. Compression stockings can not prevent post-thrombotic syndrome[J]. MMW Fortschr Med, 2014, 156(4): 33.
|
| [23] |
Kanaan A. Elastic compression stockings fail to prevent post-thrombotic syndrome after a first deep vein thrombosis[J]. Evid Based Nurs, 2015, 18(1): 22.
|
| [24] |
Rabe E, Partsch H, Hafner J, et al. Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement[J]. Phlebology, 2018, 33(3): 163-184.
|
| [25] |
Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial[J]. Lancet, 2014, 383(9920): 880-888.
|
| [26] |
Padberg FT Jr, Johnston MV, Sisto SA. Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomized trial[J]. J Vasc Surg, 2004, 39(1): 79-87.
|
| [27] |
Cohen JM, Akl EA, Kahn SR. Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials[J]. Chest, 2012, 141(2): 308-320.
|
| [28] |
Vazquez SR, Freeman A, VanWoerkom RC, et al. Contemporary issues in the prevention and management of postthrombotic syndrome[J]. Ann Pharmacother, 2009, 43(11): 1824-1835.
|
| [29] |
Baldwin MJ, Moore HM, Rudarakanchana N, et al. Post-thrombotic syndrome: a clinical review[J]. J Thromb Haemost, 2013, 11(5): 795-805.
|
| [30] |
Khanna AK, Singh S. Postthrombotic syndrome: surgical possibilities[J]. Thrombosis, 2012: 520604.
|
| [31] |
Busuttil A, Lim CS, Davies AH. Post thrombotic syndrome[J]. Adv Exp Med Biol, 2017, 906: 363-375.
|
| [32] |
Kahn SR. The post-thrombotic syndrome[J]. Hematology Am Soc Hematol Educ Program, 2016: 413-418.
|
| [33] |
Wen-da W, Yu Z, Yue-Xin C. Stenting for chronic obstructive venous disease: A current comprehensive meta-analysis and systematic review[J]. Phlebology, 2016, 31(6): 376-389.
|
| [34] |
Raju S. Treatment of iliac-caval outflow obstruction[J]. Semin Vasc Surg, 2015, 28(1): 47-53.
|
| [35] |
Seager MJ, Busuttil A, Dharmarajah B, et al. Editor's choice--a systematic review of endovenous stenting in chronic venous disease secondary to iliac vein obstruction[J]. Eur J Vasc Endovasc Surg, 2016, 51(1): 100-120.
|
| [36] |
Falcoz MT, Falvo N, Aho-Glélé S, et al. Endovascular stent placement for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions: a single-center study of safety, efficacy and quality-of-life improvement[J]. Quant Imaging Med Surg, 2016, 6(4): 342-352.
|
| [37] |
Jeraj L, Jezovnik MK, Poredos P. Insufficient recanalization of thrombotic venous occlusion-risk for postthrombotic syndrome[J]. J Vasc Interv Radiol, 2017, 28(7): 941-944.
|
| [38] |
de Wolf MA, de Graaf R, Kurstjens RL, et al. Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent[J]. Eur J Vasc Endovasc Surg, 2015, 50(4): 518-526.
|
| [39] |
Jalaie H, Arnoldussen C, Barbati M, et al. What predicts outcome after recanalization of chronic venous obstruction: hemodynamicfactors, stent geometry, patient selection, anticoagulation or other factors?[J]. Phlebology, 2014, 29(1 suppl): 97-103.
|
| [40] |
Roy M, Sasson M, Rosales-Velderrain A, et al. Pharmacomechanical thrombolysis for deep vein thrombosis in May-Thurner syndrome[J]. Innovations (Phila), 2017, 12(6): 466-471.
|
| [41] |
Lee KA, Ramaswamy RS. Interventional approaches to deep venous thrombosis[J]. Curr Opin Cardiol, 2017, 32(6): 679-686.
|
| [42] |
Jalaie H, Schleimer K, Barbati ME, et al. Interventional treatment of postthrombotic syndrome[J]. Gefasschirurgie, 2016, 21(Suppl 2): 37-44.
|
| [43] |
Razavi MK, Jaff MR, Miller LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and Meta-analysis[J]. Circ Cardiovasc Interv, 2015, 8(10): e002772.
|
| [44] |
中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第2版)[J]. 中华外科杂志, 2012, 50(7): 611-614.
|